Pacira Biosciences earnings were -$90.7M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest PCRX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$143.5M, down 859.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PCRX reported annual earnings of $42.0M, with 163.7% growth. The next PCRX earnings date is Feb 26, 2025.
What were Pacira Biosciences's earnings last quarter?
On PCRX's earnings call on Invalid Date, Pacira Biosciences (NASDAQ: PCRX) reported Q3 2024 earnings per share (EPS) of -$3.11, up 1,452.17% year over year. Total PCRX earnings for the quarter were -$143.47 million. In the same quarter last year, Pacira Biosciences's earnings per share (EPS) was $0.23.
The next PCRX earnings call is Invalid Date. Add PCRX to your watchlist to be reminded of Pacira Biosciences's next earnings date.
What was PCRX's earnings growth in the past year?
As of Pacira Biosciences's earnings date in Invalid Date, Pacira Biosciences's earnings has grown year over year. PCRX earnings in the past year totalled -$90.73 million.
Is Pacira Biosciences profitable or losing money?
As of the last Pacira Biosciences earnings report, Pacira Biosciences is currently losing money. Pacira Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$90.73 million, a 1,399.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.